Bulletin
Investor Alert

Clovis Oncology Inc.

NAS: CLVS

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201295534/composite

$

2.23

Change

+0.04 +1.83%

Volume

Volume 82,999

Jan 21, 2022, 7:55 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201295534/composite

Previous close

$ 2.33

$ 2.19

Change

-0.14 -6.01%

Day low

Day high

$2.18

$2.40

Open
Open: 2.29

52 week low

52 week high

$2.18

$11.10

Open

Market cap

$284.65M

Average volume

4.22M

P/E ratio

N/A

Rev. per Employee

$363,841

EPS

-2.83

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/clvs

MarketWatch News on CLVS

  1. Clovis Oncology downgraded to underperform from market perform at SVB Leerink

    5:25 a.m. April 27, 2020

    - Tomi Kilgore

  2. Clovis Oncology stock price target cut to $5 from $10 at SVB Leerink

    5:26 a.m. April 27, 2020

    - Tomi Kilgore

  3. Pfizer’s New Strategy Makes It Worth Another Look

    2:52 p.m. Dec. 4, 2019

    - Barron's Online

  4. Three momentum stocks to watch after company earnings reports

    12:50 p.m. Nov. 22, 2019

    - Harry Boxer

  5. Clovis Oncology stock price target cut to $8 from $12 at Evercore ISI

    7:42 a.m. Nov. 19, 2019

    - Tomi Kilgore

  6. Clovis Oncology downgraded to in line from outperform at Evercore ISI

    7:42 a.m. Nov. 19, 2019

    - Tomi Kilgore

  7. The Dow Is Up Because There’s a Little More Hope About Trade

    8:16 a.m. Sept. 24, 2019

    - Barron's Online

  8. Clovis Oncology Falls After Analyst Blasts New Licensing Deal

    8:02 a.m. Sept. 24, 2019

    - Barron's Online

  9. Clovis Oncology downgraded to market perform from outperform at SVB Leerink

    7:49 a.m. Sept. 24, 2019

    - Tomi Kilgore

  10. Clovis Oncology stock price target cut to $10 from $21 at SVB Leerink

    7:49 a.m. Sept. 24, 2019

    - Tomi Kilgore

  11. Clovis Oncology stock price target cut to $22 from $40 at SVB Leerink

    7:27 a.m. Aug. 2, 2019

    - Tomi Kilgore

  12. The Dow is tumbling as recession fears meet the trade war

    10:56 a.m. May 29, 2019

    - Barron's Online

  13. Clovis Oncology Shares Drop on Cancer Drug Potential

    9:08 a.m. May 29, 2019

    - Barron's Online

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/clvs

Other News on CLVS

  1. 6 Top Biotech Ideas For 2022

    9:28 a.m. Jan. 20, 2022

    - Seeking Alpha

  2. 2 Cancer Stocks With Absurdly Low Valuations

    10:15 a.m. Jan. 19, 2022

    - Motley Fool

  3. Why Is Clovis (CLVS) Down 32% Since Last Earnings Report?

    11:31 a.m. Dec. 3, 2021

    - Zacks.com

  4. Warning: CLVS is at high risk of performing badly

    4:50 a.m. Nov. 16, 2021

    - Seeking Alpha

  5. Clover Health starts offering 35 million of common stock

    4:38 p.m. Nov. 15, 2021

    - Seeking Alpha

  6. Clovis (CLVS) Q3 Loss Wider Than Expected, Revenues Lag

    6:46 a.m. Nov. 4, 2021

    - Zacks.com

  7. 10-Q: CLOVIS ONCOLOGY, INC.

    4:48 p.m. Nov. 3, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  8. Clovis Oncology EPS misses by $0.08, misses on revenue

    8:04 a.m. Nov. 3, 2021

    - Seeking Alpha

  9. Clovis Oncology Q3 2021 Earnings Preview

    11:32 a.m. Nov. 2, 2021

    - Seeking Alpha

  10. Notable earnings before Wednesday's open

    11:20 a.m. Nov. 2, 2021

    - Seeking Alpha

  11. Loading more headlines...
/news/pressrelease/company/us/clvs

Press Releases on CLVS

  1. Clovis Oncology Announces Third Quarter 2021 Operating Results

    7:00 a.m. Nov. 3, 2021

    - BusinessWire - BZX

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.